These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 26609935)
1. Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus. Diaz FM; Knipe DM Virology; 2016 Jan; 488():61-7. PubMed ID: 26609935 [TBL] [Abstract][Full Text] [Related]
2. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Da Costa XJ; Morrison LA; Knipe DM Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897 [TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. Morrison LA; Zhu L; Thebeau LG J Virol; 2001 Feb; 75(3):1195-204. PubMed ID: 11152492 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs. Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802 [TBL] [Abstract][Full Text] [Related]
5. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2. Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846 [TBL] [Abstract][Full Text] [Related]
6. Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge. Morello CS; Kraynyak KA; Levinson MS; Chen Z; Lee KF; Spector DH Vaccine; 2012 Oct; 30(46):6541-6550. PubMed ID: 22947141 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4 Srivastava R; Roy S; Coulon PG; Vahed H; Prakash S; Dhanushkodi N; Kim GJ; Fouladi MA; Campo J; Teng AA; Liang X; Schaefer H; BenMohamed L J Virol; 2019 May; 93(9):. PubMed ID: 30787156 [TBL] [Abstract][Full Text] [Related]
8. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes. Awasthi S; Huang J; Shaw C; Friedman HM J Virol; 2014 Aug; 88(15):8421-32. PubMed ID: 24829358 [TBL] [Abstract][Full Text] [Related]
9. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens. Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292 [TBL] [Abstract][Full Text] [Related]
10. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407 [TBL] [Abstract][Full Text] [Related]
11. Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein. Reszka NJ; Dudek T; Knipe DM Vaccine; 2010 Mar; 28(15):2754-62. PubMed ID: 20117270 [TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Da Costa XJ; Bourne N; Stanberry LR; Knipe DM Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583 [TBL] [Abstract][Full Text] [Related]
14. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. van Lint AL; Torres-Lopez E; Knipe DM Virology; 2007 Nov; 368(2):227-31. PubMed ID: 17915278 [TBL] [Abstract][Full Text] [Related]